Lancet:1990-2019全球听力受损患病率研究

2021-03-13 MedSci原创 MedSci原创

随着人口老龄化程度的加剧,听力受损患者人群将不断增加,适当的干预,如儿童筛查、助听器、中耳炎和脑膜炎治疗以及耳蜗植入等措施,都对减轻听力受损负担有益

听力损失的原因有很多,当个人的沟通需求无法得到满足时,会对生活多个方面产生负面影响。 长期的听力损失会降低患者生活质量和口语交流的机会,阻碍儿童语言能力发展,导致老年痴呆症和认知能力下降。
近日研究人员通过2019全球疾病负担研究(GBD),考察了听力损失的患病率及致残情况。
研究人员对1990-2019年间,人群代表的听力损失患病率调查研究进行了系统的回顾,对严重程度特异性患病率进行考察,计算了助听器覆盖率、原因和耳鸣的存在。 同时预测了到2050年听力损失的患病率。
 
2018年,全球听力受损人群总计15.7亿,其中每5人中就有1人听力受损(20.3%),4.03亿中重度听力受损患者佩戴了助听器,4.3亿未佩戴助听器,西太平洋地区是中度至完全听力损失患者人数最多的地区,约1.27亿。对于佩戴助听器人群,50岁以上人占62.1%。医疗质量和可及性指数(HAQ)与年龄调整后听力损失造成的残疾指数相关,HAQ指数较低地区的残疾指数较高。预测到2050年,听力损失患者人数将达到24.5亿,较2019年增加56.1%,而年龄标准化患病率将保持稳定。
 
随着人口老龄化程度的加剧,听力受损患者人群将不断增加,适当的干预,如儿童筛查、助听器、中耳炎和脑膜炎治疗以及耳蜗植入等措施,都对减轻听力受损负担有益。
 
原始出处:
 

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1831068, encodeId=ae7b1831068c0, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Jul 22 07:41:05 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677829, encodeId=fe9a16e782965, content=<a href='/topic/show?id=cc1239241d0' target=_blank style='color:#2F92EE;'>#听力受损#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39241, encryptionId=cc1239241d0, topicName=听力受损)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab9027602089, createdName=chaojitidian, createdTime=Sat Aug 14 15:41:05 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250729, encodeId=40e11250e29a6, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Mon Mar 15 01:41:05 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306639, encodeId=4168130663910, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Mon Mar 15 01:41:05 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034214, encodeId=e05710342142f, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Sat Mar 13 13:41:05 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947830, encodeId=96c994e83012, content=关爱听力, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f735449673, createdName=ms4000001153850205, createdTime=Sat Mar 13 11:37:18 CST 2021, time=2021-03-13, status=1, ipAttribution=)]
    2021-07-22 howi
  2. [GetPortalCommentsPageByObjectIdResponse(id=1831068, encodeId=ae7b1831068c0, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Jul 22 07:41:05 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677829, encodeId=fe9a16e782965, content=<a href='/topic/show?id=cc1239241d0' target=_blank style='color:#2F92EE;'>#听力受损#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39241, encryptionId=cc1239241d0, topicName=听力受损)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab9027602089, createdName=chaojitidian, createdTime=Sat Aug 14 15:41:05 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250729, encodeId=40e11250e29a6, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Mon Mar 15 01:41:05 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306639, encodeId=4168130663910, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Mon Mar 15 01:41:05 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034214, encodeId=e05710342142f, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Sat Mar 13 13:41:05 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947830, encodeId=96c994e83012, content=关爱听力, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f735449673, createdName=ms4000001153850205, createdTime=Sat Mar 13 11:37:18 CST 2021, time=2021-03-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1831068, encodeId=ae7b1831068c0, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Jul 22 07:41:05 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677829, encodeId=fe9a16e782965, content=<a href='/topic/show?id=cc1239241d0' target=_blank style='color:#2F92EE;'>#听力受损#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39241, encryptionId=cc1239241d0, topicName=听力受损)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab9027602089, createdName=chaojitidian, createdTime=Sat Aug 14 15:41:05 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250729, encodeId=40e11250e29a6, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Mon Mar 15 01:41:05 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306639, encodeId=4168130663910, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Mon Mar 15 01:41:05 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034214, encodeId=e05710342142f, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Sat Mar 13 13:41:05 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947830, encodeId=96c994e83012, content=关爱听力, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f735449673, createdName=ms4000001153850205, createdTime=Sat Mar 13 11:37:18 CST 2021, time=2021-03-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1831068, encodeId=ae7b1831068c0, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Jul 22 07:41:05 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677829, encodeId=fe9a16e782965, content=<a href='/topic/show?id=cc1239241d0' target=_blank style='color:#2F92EE;'>#听力受损#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39241, encryptionId=cc1239241d0, topicName=听力受损)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab9027602089, createdName=chaojitidian, createdTime=Sat Aug 14 15:41:05 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250729, encodeId=40e11250e29a6, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Mon Mar 15 01:41:05 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306639, encodeId=4168130663910, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Mon Mar 15 01:41:05 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034214, encodeId=e05710342142f, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Sat Mar 13 13:41:05 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947830, encodeId=96c994e83012, content=关爱听力, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f735449673, createdName=ms4000001153850205, createdTime=Sat Mar 13 11:37:18 CST 2021, time=2021-03-13, status=1, ipAttribution=)]
    2021-03-15 ysjykql
  5. [GetPortalCommentsPageByObjectIdResponse(id=1831068, encodeId=ae7b1831068c0, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Jul 22 07:41:05 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677829, encodeId=fe9a16e782965, content=<a href='/topic/show?id=cc1239241d0' target=_blank style='color:#2F92EE;'>#听力受损#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39241, encryptionId=cc1239241d0, topicName=听力受损)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab9027602089, createdName=chaojitidian, createdTime=Sat Aug 14 15:41:05 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250729, encodeId=40e11250e29a6, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Mon Mar 15 01:41:05 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306639, encodeId=4168130663910, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Mon Mar 15 01:41:05 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034214, encodeId=e05710342142f, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Sat Mar 13 13:41:05 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947830, encodeId=96c994e83012, content=关爱听力, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f735449673, createdName=ms4000001153850205, createdTime=Sat Mar 13 11:37:18 CST 2021, time=2021-03-13, status=1, ipAttribution=)]
    2021-03-13 goodbing

    顶刊就是不一样,质量很高,内容精彩!学到很多

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1831068, encodeId=ae7b1831068c0, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Thu Jul 22 07:41:05 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677829, encodeId=fe9a16e782965, content=<a href='/topic/show?id=cc1239241d0' target=_blank style='color:#2F92EE;'>#听力受损#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39241, encryptionId=cc1239241d0, topicName=听力受损)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab9027602089, createdName=chaojitidian, createdTime=Sat Aug 14 15:41:05 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1250729, encodeId=40e11250e29a6, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Mon Mar 15 01:41:05 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306639, encodeId=4168130663910, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Mon Mar 15 01:41:05 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034214, encodeId=e05710342142f, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Sat Mar 13 13:41:05 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947830, encodeId=96c994e83012, content=关爱听力, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f735449673, createdName=ms4000001153850205, createdTime=Sat Mar 13 11:37:18 CST 2021, time=2021-03-13, status=1, ipAttribution=)]
    2021-03-13 ms4000001153850205

    关爱听力

    0

相关资讯

Otol Neurotol:儿科患者中突发感音神经性耳聋与复发性中耳炎的关系研究

突发感音神经性耳聋(SSNHL)的风险在慢性中耳炎患者中增加。最近,哟研究人员在患有复发性中耳炎患者中扩展了之前的发现。

Eur Arch Otorhinolaryngol :急性中耳炎患者中扩展高频听力测定恢复时间与炎症持续时间关系研究

最近,有研究人员调查了扩展高频(EHF)听力测定恢复在急性中耳炎患者中的规律。

PLoS One: 包含一种新的抗菌合成多肽滴耳液在慢性化脓性中耳炎患者中的安全性和效果评估

慢性化脓性中耳炎(CSOM)是一种慢性传染病,并且在世界范围内流行。该病能够引起听力损失并降低生活质量。目前的抗生素治疗常常不成功,并且不断出现抗生素抗性,因此,迫切需要可选择的药物和/或策略。

Ear Nose Throat J:治疗慢性中耳炎手术术后感音神经性听力损失发病率调查

最近,有研究人员调查了慢性中耳炎(COM)手术后感音神经性听力损失(SNHL)的发生率,并确定了相关因素。

Audiol Neurootol:在渗出性中耳炎儿童中使用移动应用评估听力阈值研究

渗出性中耳炎(OME)是儿童中最常见的听力损失发病诱因。由于听力损失影响儿童言语和语言发展,因此早期的诊断时非常重要的。最近,有研究人员比较了传统的听力测定与安卓操作系统为基础的应用Hearing TestTM在评估OME儿童听力阈值方面的情况,并确定了移动应用测定的准确度和可靠性。研究包括了50名5岁到15岁且患有OME的学龄儿童,他们至少有1只耳朵患有OME。研究人员首先通过传统的听力测定方法

Otolaryngol Head Neck Surg:婴幼儿早期鼓膜置管的长期中耳炎结果分析

最近,有研究人员评估了没有通过新生儿听力筛选(NBHS)并因渗出性中耳炎(OME)进行了早期鼓膜置管的婴幼儿的耳科结果情况。